Exagen Inc.

XGN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$15,115-$23,689-$47,387-$26,851
Dep. & Amort.$1,724$2,168$1,557$948
Deferred Tax$0$0-$306$148
Stock-Based Comp.$1,763$3,617$4,704$4,728
Change in WC-$3,076$325$1,670-$61
Other Non-Cash$1,425$3,117$7,618$819
Operating Cash Flow-$13,279-$14,462-$32,144-$20,269
Investing Activities
PP&E Inv.-$515-$828-$4,318-$2,370
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$24$0-$50
Investing Cash Flow-$515-$804-$4,318-$2,420
Financing Activities
Debt Repay.-$861-$10,938-$696-$525
Stock Issued$198$306$446$69,144
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0-$239-$3,936
Financing Cash Flow-$663-$10,632-$489$64,683
Forex Effect$0$0$0$0
Net Chg. in Cash-$14,457-$25,898-$36,951$41,994
Supplemental Information
Beg. Cash$36,693$62,591$99,542$57,548
End Cash$22,236$36,693$62,591$99,542
Free Cash Flow-$13,794-$15,290-$36,462-$22,639
Exagen Inc. (XGN) Financial Statements & Key Stats | AlphaPilot